Latest update January 15th, 2021 3:58 PM
Nov 30, 2020 admin PRESS RELEASES Comments Off on Sinch AB (publ): Sinch announces its intention to carry out a directed new share issue and large shareholders’ intention to sell existing shares to a fund managed by SB Management
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION...Nov 30, 2020 admin PRESS RELEASES Comments Off on Philips expands its healthcare customer services portfolio with the introduction of integrated Cybersecurity Services
November 30, 2020 Philips partners with CyberMDX, a leader in connected medical device security, to provide vendor-neutral solutions to protect connected medical systems and devices Amsterdam, the...Nov 30, 2020 admin PRESS RELEASES Comments Off on Philips introduces next generation of Advanced Visualization Workspace – IntelliSpace Portal 12 – with AI capabilities at RSNA 2020
November 30, 2020 Next generation of Philips’ advanced radiology visualization platform leverages image post-processing and artificial intelligence (AI) to deliver quantitative clinical insights,...Nov 30, 2020 admin PRESS RELEASES Comments Off on Bombardier Appoints Bart Demosky Executive Vice President and Chief Financial Officer
MONTREAL, Nov. 30, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) announced today the appointment of Bart Demosky as Executive Vice President and Chief Financial Officer, effective immediately....Nov 30, 2020 admin PRESS RELEASES Comments Off on Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage...Nov 30, 2020 admin PRESS RELEASES Comments Off on Novavax Announces COVID-19 Vaccine Clinical Development Progress
Pivotal Phase 3 trial in United Kingdom completes enrollment Phase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks GAITHERSBURG,...